Meeting
2022 ASCO Annual Meeting
Effect of primary tumor sidedness on the association of tumor-infiltrating lymphocytes with survival of patients with stage III colon cancer (NCCTG N0147) [alliance].
Presenter
Bahar Saberzadeh Ardestani, MD, MPH
Mayo Clinic
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Biologic Correlates
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3525)
DOI
10.1200/JCO.2022.40.16_suppl.3525
Abstract #
3525
Poster Bd #
319
Abstract Disclosures
Similar Videos & Slides
Speaker: Shang-Jui Wang, MD, PhD
Videos & Slides
2024 ASCO Gastrointestinal Cancers Symposium
AZUR-2, a phase III, open-label, randomized study of perioperative dostarlimab monotherapy vs standard of care in previously untreated patients with T4N0 or stage III dMMR/MSI-H resectable colon cancer.
Speaker: Naureen Starling, MD, MBBS, FRCP, BSc
Speaker: Panel Discussion
Videos & Slides
2023 ASCO Gastrointestinal Cancers Symposium
LEANOX: Lean body mass normalization of oxaliplatin-based chemotherapy for patients with stage III colon cancer treated in adjuvant setting: Impact on oxaliplatin-induced sensitive neurotoxicity—A multicenter phase II randomized trial.
Speaker: Eric Assenat, MD PhD